Skip to main content
. 2022 May 14;22:548. doi: 10.1186/s12885-022-09656-4

Fig. 5.

Fig. 5

Immune status and prognosis. Disease-free survival analysis based on TILs subgroups (a) and immune score (c); Distant metastasis-free survival analysis based on TILs subgroups (b) and immune score (d)